Semin Plast Surg 2022; 36(01): 017-025
DOI: 10.1055/s-0042-1742750
Review Article

Use of Biologic Agents in Nasal and Scalp Reconstruction

Monal Depani
1   Department of Plastic Surgery, University of Texas Southwestern Medical Center, Dallas, Texas
,
Andrew E. Grush
2   Division of Plastic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas
3   Division of Plastic Surgery, Department of Surgery, Texas Children's Hospital, Houston, Texas
,
Matthew J. Parham
2   Division of Plastic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas
3   Division of Plastic Surgery, Department of Surgery, Texas Children's Hospital, Houston, Texas
,
Lloyd M. Jones
2   Division of Plastic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas
3   Division of Plastic Surgery, Department of Surgery, Texas Children's Hospital, Houston, Texas
,
James F. Thornton
1   Department of Plastic Surgery, University of Texas Southwestern Medical Center, Dallas, Texas
› Author Affiliations

Abstract

Oncologic reconstruction of the nose and scalp following Mohs micrographic surgery poses a significant challenge for plastic surgeons. While these defects are traditionally reconstructed using primary closure techniques, skin grafts, local flaps, pedicled flaps, and free tissue transfer, the incorporation of biologic healing wound agents such as Integra and Cytal provides patients and surgeons with alterative reconstructive options without additional donor site morbidity. Herein, we review the use of biologic agents used in soft tissue reconstruction of the nose and scalp following Mohs surgery.



Publication History

Article published online:
09 March 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA